Antipsychotics Flashcards
Haloperidol (a butyrophenone)
- typical antipsychotic
high potency, high incidence of motor SE, low anticholinergic + antiandrenergic effects,
significant 1st pass metabolism
Mechanism: Blocks 75% of D2 receptors at clinically effective doses – inhibits mesolimbic & mesocortical DA receptors –> antipsychotic efficacy
- Chronic administration inhibits pathways by DA accumulation & depolarization blockade (2-3 weeks)
Use: (+) symptoms
- Delusions
- Hallucinations
Also used for behavioral syndromes accompanied by motor disturbances – Gilles de la Tourette’s
Toxicity:
inhibition of basal ganglia DA receptors: motor SE
inhibitions of tuberoinfundibular DA receptors: inc. prolactin secretion
- Short term use: Parkinson-like motor effects (nigrostriatal block)
- Long term use (mo-yrs): perioral tremor (rabbit face) & permanent tardive dyskinesia
- Hyperprolactinemia (tuberoinfundibular block) leading to menstrual irregularity, galactorrhea
- Low anticholinergic & antiadrenergic effects:
dry mouth, urinary retention (M block);
orthostatic hypotension, reflex tachycardia (α1 block); sedation (hist block)
- Weight gain
- Prolonged QT interval
- Neuroleptic malignant syndrome (rare ANS collapse)
Metabolism: - Lipid soluble
- Significant first pass metabolism
- Pregnancy category C (benefit > risk)
Clozapine
- atypical antipsychotic
Mechanism:
Blocks 50% of D2 receptors & 80% of 5-HT2A receptors at clinically effective doses
- Chronic administration inhibits pathways by DA accumulation & depolarization blockade (2-3 weeks)
Use: (+ & -) symptoms
- Delusions
- Hallucinations
- Flattened affect
- Emotional or social withdrawal
Risperidone also used for bipolar disorder
Toxicity: - Agnranulocytosis – requires regular blood testing
- Weight gain w/ insulin resistance & diabetes mellitus
- Hyperlipidemia
- Low incidence of motor side-effects
Interaction: - Lipid soluble
- Significant first pass metabolism
- Pregnancy category B
Risperidone
- atypical antipsychotic
Mechanism:
Blocks 50% of D2 receptors & 80% of 5-HT2A receptors at clinically effective doses
- Chronic administration inhibits pathways by DA accumulation & depolarization blockade (2-3 weeks)
Use: (+ & -) symptoms
- Delusions
- Hallucinations
- Flattened affect
- Emotional or social withdrawal
Risperidone also used for bipolar disorder
Toxicity: - Weight gain & diabetes mellitus
- Hyperlipidemia
- Minor extrapyramidal sx & hyperprolactinemia